BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6142074)

  • 1. Characterization of somatostatin in peripheral and portal plasma in the duck: in-vivo metabolism of somatostatin-28 and -14.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    J Endocrinol; 1984 Mar; 100(3):329-35. PubMed ID: 6142074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin-like immunoreactivity (SLI) in pancreatic and intestinal tissues of the duck. A possible origin for the portal circulating SLI.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    Horm Metab Res; 1985 Nov; 17(11):566-71. PubMed ID: 2867025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence of somatostatin 28 in plasma.
    Shoelson S; Polonsky K; Docherty H; Jaspan J; Rubenstein A
    Diabetes; 1982 May; 31(5 Pt 1):474-7. PubMed ID: 6130021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological activity of duck 'big' somatostatin on chicken adipose tissue.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    Biochim Biophys Acta; 1985 May; 845(2):261-4. PubMed ID: 2859895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-like immunoreactivity in duck plasma, hypothalamus and neural lobe during post-hatch growth: comparison with plasma and pituitary growth hormone concentrations.
    Foltzer C; Harvey S; Mialhe P
    J Endocrinol; 1987 Apr; 113(1):57-63. PubMed ID: 2884270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo metabolism of somatostatin 28: possible relationship between diminished metabolism and enhanced biological action.
    Polonsky K; Jaspan J; Berelowitz M; Pugh W; Moossa A; Ling N
    Endocrinology; 1982 Nov; 111(5):1698-703. PubMed ID: 6127205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin-like immunoreactivity in man. Measurement in peripheral plasma.
    Tronier B; Larsen UD
    Diabete Metab; 1982 Mar; 8(1):35-40. PubMed ID: 6124467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of substance P and neurotensin on somatostatin levels in rat portal plasma.
    Saito H; Saito S
    Endocrinology; 1980 Nov; 107(5):1600-5. PubMed ID: 6159202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the accuracy of radioimmunological determination of somatostatin in plasma.
    Hilsted L; Holst JJ
    Regul Pept; 1982 Jun; 4(1):13-31. PubMed ID: 6126917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma somatostatin 28 increases in response to feeding in man.
    Polonsky KS; Shoelson SE; Docherty HM
    J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of plasma somatostatin-like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subjects and patients with impaired glucose tolerance.
    Itoh M; Hirooka Y; Nihei N
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):468-74. PubMed ID: 6140806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
    Patel YC; Ganda OP; Benoit R
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of immunoreactive somatostatin by perfused rat liver.
    Sacks H; Terry LC
    J Clin Invest; 1981 Feb; 67(2):419-29. PubMed ID: 6109737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersomatostatinemia in chronic renal failure.
    Wasada T; Inoue K; Fujimi S; Sako Y; Hisatomi A; Ibayashi H
    Endocrinol Jpn; 1987 Apr; 34(2):251-6. PubMed ID: 2887424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid.
    Fitz-Patrick D; Patel YC
    J Clin Invest; 1979 Sep; 64(3):737-42. PubMed ID: 468988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for somatostatin precursors in human stomach, placenta, and amniotic fluid.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):372-6. PubMed ID: 6114109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.
    Conlon JM; Srikant CB; Ipp E; Schusdziarra V; Vale W; Unger RH
    J Clin Invest; 1978 Dec; 62(6):1187-93. PubMed ID: 748373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin-like immunoreactivity in mammalian thyroid glands: contents and partial characterization.
    Oyama H; Kameda Y; Endoh M; Nagase Y; Matsuki M; Kakita K; Tenku A; Nishida S; Horino M
    Endocrinology; 1984 Mar; 114(3):1028-32. PubMed ID: 6141931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.